Join Mayo Clinic Laboratories for our webinar exploring the expanding role of precision diagnostics in the evaluation of serious and potentially life-threatening infections. Focusing on metagenomic sequencing available from Mayo Clinic Laboratories, including the Karius Spectrum plasma test, which is offered by Mayo Clinic Laboratories in collaboration with Karius, participants will gain an overview of microbial cell-free DNA (mcfDNA) metagenomic sequencing, including clinical decision-making around test ordering, appropriate clinical indications, and how to interpret and apply results to support timely diagnosis and patient management.

On Friday, Oct. 9, from noon to 1 p.m. CT, learn more about how metagenomic sequencing has emerged as a precision technique to quickly and accurately diagnose serious, hospital-acquired infections — which is particularly important for immunocompromised patients. This webinar is presented by Matthew Binnicker, Ph.D., chief scientific officer for Mayo Clinic Laboratories, and Omar Abu Saleh, M.B.B.S., an associate professor of medicine and infectious disease specialist at Mayo Clinic.

Don't miss this opportunity to learn how metagenomic sequencing provides a deeper level of detection for hard-to-diagnose pathogens through rapid and unbiased analysis.

For questions, contact us at mcleducation@mayo.edu.